{"id":128562,"date":"2021-02-04T08:53:38","date_gmt":"2021-02-04T05:53:38","guid":{"rendered":"https:\/\/www.enerjigazetesi.ist\/?p=128562"},"modified":"2021-02-04T08:54:53","modified_gmt":"2021-02-04T05:54:53","slug":"4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz","status":"publish","type":"post","link":"https:\/\/www.enerjigazetesi.ist\/en\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz\/","title":{"rendered":"(Turkish) 4 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc: Kanseri Nas\u0131l Yenece\u011fiz?"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-en\">Sorry, this entry is only available in <a href=\"https:\/\/www.enerjigazetesi.ist\/tr\/wp-json\/wp\/v2\/posts\/128562\" class=\"qtranxs-available-language-link qtranxs-available-language-link-tr\" title=\"Turkish\">Turkish<\/a>. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.<\/p><p><\/p>\n<h1><strong>Her y\u0131l d\u00fcnyada ortalama 18 milyon ki\u015fiye, T\u00fcrkiye\u2019de ise 163 bin ki\u015fiye kanser tan\u0131s\u0131 konuyor. T\u0131p d\u00fcnyas\u0131 4 \u015eubat Kanser G\u00fcn\u00fc\u2019nde \u015fu sorunun yan\u0131t\u0131n\u0131 aramaya devam ediyor:<em> \u201c\u0130yile\u015fme oranlar\u0131 artacak, \u00f6l\u00fcm oranlar\u0131 d\u00fc\u015fecek mi?\u201d<\/em> Kanser tedavisinde umut verici geli\u015fmeler var.<\/strong><\/h1>\n<p><strong>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc<\/strong>\u2019ne g\u00f6re <strong>2030 y\u0131l\u0131nda<\/strong> t\u00fcm d\u00fcnyada <strong>22 milyon yeni kanser tan\u0131s\u0131<\/strong> olacak. Peki kanserle m\u00fccadelede ba\u015far\u0131y\u0131 ne zaman sa\u011flanacak, <strong>\u00e7a\u011f\u0131n hastal\u0131\u011f\u0131 kanseri<\/strong> nas\u0131l yenece\u011fiz? Maltepe \u00dcniversitesi T\u0131p Fak\u00fcltesi T\u0131bbi Onkoloji Uzman\u0131 <strong>Prof. Dr. Orhan T\u00fcrken<\/strong> kanserle m\u00fccadeledeki geli\u015fmeleri, tan\u0131 ve tedavinin gelece\u011fini anlatt\u0131. <strong>Teknolojik geli\u015fme<\/strong> ve <strong>yeniliklerle <img loading=\"lazy\" class=\"alignright wp-image-128564\" src=\"https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz.jpg\" alt=\"\" width=\"320\" height=\"320\" srcset=\"https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz.jpg 550w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz-150x150.jpg 150w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz-300x300.jpg 300w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz-400x400.jpg 400w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz-50x50.jpg 50w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz-100x100.jpg 100w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2021\/02\/4-subat-dunya-kanser-gunu-kanseri-nasil-yenecegiz-500x500.jpg 500w\" sizes=\"(max-width: 320px) 100vw, 320px\" \/>do\u011fru tan\u0131<\/strong> oranlar\u0131n\u0131n artt\u0131\u011f\u0131na dikkat \u00e7eken <strong>Prof. Dr. T\u00fcrken<\/strong>, <em>\u201cKanser en ileri devrede bile tedavi edilebilir bir hastal\u0131k haline gelecek\u201d<\/em> dedi.<\/p>\n<p>\u00d6zellikle s\u0131k g\u00f6r\u00fclen kanserlerde \u00f6nerilen tarama programlar\u0131 ile erken te\u015fhis oranlar\u0131nda ciddi art\u0131\u015flar oldu\u011funu s\u00f6yleyen Prof. T\u00fcrken, <em>\u201cTarama programlar\u0131yla hen\u00fcz belirti vermeyen bir\u00e7ok <strong>kanser \u00e7ok erken evrelerde<\/strong> tespit edilebiliyor. Bilin\u00e7lenmenin art\u0131\u015f\u0131 ile <strong>aile bireylerinde kanserli yak\u0131nlar\u0131<\/strong> olanlar\u0131n kendi istekleri ile <strong>kontrol edilmeleri, hafif yak\u0131nmalar\u0131<\/strong> olanlar\u0131n vakit ge\u00e7irmeden bir sa\u011fl\u0131k kurumuna ba\u015fvurmalar\u0131 <strong>erken te\u015fhis oranlar\u0131n\u0131<\/strong> artt\u0131rd\u0131. \u00a0<strong>T\u0131bbi cihazlar<\/strong> ve kullan\u0131lan malzemelerin de teknolojik geli\u015fmelere paralel olarak daha kaliteli olmas\u0131, \u00e7ok erken a\u015famalarda kanserli hastalar\u0131 tespit etmemize olanak sa\u011fl\u0131yor\u201d<\/em> dedi.<\/p>\n<p><strong>Erken te\u015fhis oranlar\u0131 artt\u0131. Peki ya tedavi?<\/strong> Kanser tedavisinde yeni ila\u00e7lar ve y\u00f6ntemlerle ba\u015far\u0131 \u015fans\u0131n\u0131n art\u0131k daha fazla oldu\u011funa dikkat \u00e7eken Prof. Dr. T\u00fcrken, erken te\u015fhislerin artmas\u0131 ile \u00f6l\u00fcm oranlar\u0131n\u0131n da azalmaya ba\u015flad\u0131\u011f\u0131n\u0131 s\u00f6yl\u00fcyor. Tedavide genel olarak <strong>cerrahi y\u00f6ntemler, \u0131\u015f\u0131n tedavisi (radyoterapi) ve ila\u00e7 tedavileri (kemoterapi ve di\u011fer sistemik tedaviler)<\/strong> uyguland\u0131\u011f\u0131n\u0131 belirten T\u00fcrken, y\u00f6ntemlerle ilgili <span style=\"text-decoration: underline;\">\u015fu bilgileri verdi:<\/span><\/p>\n<p><em>\u201cErken evrelerde cerrahi operasyon, ge\u00e7 evrelerde ila\u00e7l\u0131 tedaviler \u00f6n planda olsa da art\u0131k b\u00fct\u00fcn bu tedavilerin her evrede ard\u0131\u015f\u0131k veya birlikte uygulanabiliyor. <strong>Meme kanseri nedeni<\/strong> ile<strong> ameliyat<\/strong> edilmi\u015f bir hastaya daha sonra olu\u015fabilecek<strong> n\u00fcksleri \u00f6nlemek<\/strong> i\u00e7in<strong> koruyucu olarak (adjuvan) radyoterapi<\/strong> veya<strong> kemoterapi<\/strong> verilebiliyor. Ya da ileri evrede kanserli bir hastan\u0131n <strong>ila\u00e7<\/strong> veya <strong>\u0131\u015f\u0131n tedavileri<\/strong> sonras\u0131 uygun hale gelirse <strong>ameliyat<\/strong> edilebiliyor.\u201d\u00a0<\/em><\/p>\n<p>Prof. Dr. T\u00fcrken kanser tedavisinin giderek hastadan hastaya <strong>tedavi y\u00f6ntemi<\/strong> de\u011fi\u015fen, ki\u015fiye \u00f6zg\u00fc bir tedavi haline gelmeye ba\u015flad\u0131\u011f\u0131n\u0131 da vurgulad\u0131. <strong>Ki\u015fiye \u00f6zg\u00fc tedavinin<\/strong> ila\u00e7l\u0131 tedavilerde \u00f6n planda olmakla birlikte <strong>cerrahi<\/strong> ve <strong>radyoterapide<\/strong> gibi di\u011fer y\u00f6ntemler i\u00e7in de ge\u00e7erli oldu\u011funu belirten T\u00fcrken, \u00f6rneklerle<span style=\"text-decoration: underline;\"> ki\u015fiye \u00f6zg\u00fc tedaviyi \u015f\u00f6yle anlatt\u0131:<\/span><\/p>\n<p><em>\u201cHer meme<strong> kanserli hastan\u0131n<\/strong> art\u0131k b\u00fct\u00fcn <strong>meme dokusu<\/strong> al\u0131nm\u0131yor. Baz\u0131 hastalarda organ koruyucu cerrahi dedi\u011fimiz y\u00f6ntemle <strong>sadece t\u00fcm\u00f6rl\u00fc k\u0131sm\u0131<\/strong> \u00e7\u0131kar\u0131l\u0131yor. Yine radyoterapi yap\u0131lacak hastalarda da<strong> \u0131\u015f\u0131nlanan b\u00f6lgenin geni\u015fli\u011fi<\/strong> ve <strong>dozlar hastadan hastaya<\/strong> de\u011fi\u015febiliyor. Ama kanser tedavisini ki\u015fiselle\u015ftiren <strong>en b\u00fcy\u00fck geli\u015fmeler ila\u00e7l\u0131 tedavilerde<\/strong> ya\u015fanmakta. Art\u0131k <strong>klasik kemoterapi<\/strong> d\u0131\u015f\u0131nda <strong>ak\u0131ll\u0131<\/strong> denilen,<strong> hedefe y\u00f6nelik ila\u00e7lar<\/strong> ile <strong>ba\u011f\u0131\u015f\u0131kl\u0131k sistemini t\u00fcm\u00f6re kar\u015f\u0131<\/strong> daha aktif k\u0131lmay\u0131 hedefleyen<strong> imm\u00fcnoterapi<\/strong> gibi yeni tedavi se\u00e7eneklerimiz var. <strong>T\u00fcm\u00f6r h\u00fccre yap\u0131s\u0131n\u0131n<\/strong> daha iyi anla\u015f\u0131lmas\u0131 ve do\u011frudan <strong>t\u00fcm\u00f6r\u00fc hedefleyen<\/strong> yeni molek\u00fcllerin ke\u015ffi kanser tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7t\u0131. Yeni ila\u00e7larla birlikte <strong>tedavi spektrumu<\/strong> geni\u015fleyecek ve<strong> kanser<\/strong> ileri evrede bile olsa<strong> tamamen tedavi edilebilir<\/strong> bir hastal\u0131k haline gelecektir.\u201d<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Sorry, this entry is only available in Turkish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Her y\u0131l d\u00fcnyada ortalama 18 milyon ki\u015fiye, T\u00fcrkiye\u2019de ise 163 bin ki\u015fiye kanser tan\u0131s\u0131 konuyor. T\u0131p d\u00fcnyas\u0131 4 \u015eubat Kanser G\u00fcn\u00fc\u2019nde \u015fu [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":128565,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[53],"tags":[85922,52259,85924,54499,85925,85923,69120],"views":71,"_links":{"self":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/128562"}],"collection":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/comments?post=128562"}],"version-history":[{"count":0,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/128562\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media\/128565"}],"wp:attachment":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media?parent=128562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/categories?post=128562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/tags?post=128562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}